Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Cramer's Mad Dash: Abbott's a clear winner
11:48am, Wednesday, 19'th Apr 2023
CNBC's Jim Cramer delivers his daily Mad Dash.
8 Defensive Plays as Healthcare Stocks Stumble
11:13am, Wednesday, 19'th Apr 2023
Healthcare stocks have sputtered this year after performing well in 2022. A Barron's screen has identified stocks that are poised to outperform for the rest of the year.
Diversified Abbott Laboratories Could Reverse And Move Higher
10:25am, Wednesday, 19'th Apr 2023
It is no surprise that Abbott Laboratories (NYSE: ABT) produce a solid quarter. Med-tech companies like Intuitive Surgical (NASDAQ: ISRG), Boston Scientific (NYSE: BSX) and DexCom (NASDAQ: DXCM) have
Abbott (ABT) Beats Q1 Earnings and Revenue Estimates
09:55am, Wednesday, 19'th Apr 2023
Abbott (ABT) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.73 per share a year ago.
Abbott Laboratories weathers Covid-19 test slowdown to report forecast topping 1Q profit
09:23am, Wednesday, 19'th Apr 2023
Abbott Laboratories (NYSE:ABT)' first quarter earnings topped expectations with growth in business segments such as medical devices offsetting a sharp decline in Covid-19 test sales, sending its sha
Abbott Labs Shakes Off Covid Test Decline To Top First-Quarter Estimates
08:52am, Wednesday, 19'th Apr 2023
Abbott Laboratories reported better-than-expected first-quarter sales despite a slowdown from its Covid test segment. ABT stock jumped.
Abbott Labs' Sales, Earnings Defy Slowdown in Covid-19 Tests. Stock Rises.
07:31am, Wednesday, 19'th Apr 2023
The company beat analysts' expectations with first-quarter earnings of $1.03 a share on sales of $9.75 billion.
Abbott Labs stock up 2% premarket after earnings beat despite declining COVID testing sales
07:30am, Wednesday, 19'th Apr 2023
Abbott Laboratories stock ABT, -0.35% rose 2% in premarket trade Wednesday, after the diagnostics and medical device company beat earnings estimates for the first quarter, although declining sales of
Final Trades: JPMorgan, Abbott Labs, UnitedHealth & more
01:51pm, Monday, 17'th Apr 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Abbott (ABT) Gets FDA Clearance for FreeStyle Libre 3 Reader
09:08am, Monday, 17'th Apr 2023
Abbott (ABT) receives the FDA clearance for a standalone reader to be used for the FreeStyle Libre 3 iCGM system.
What To Expect From Abbott's Q1?
08:00am, Thursday, 13'th Apr 2023
Abbott will see a decline in sales given the forex headwinds and lower Covid-19-related testing demand.
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
12:09pm, Wednesday, 12'th Apr 2023
Abbott Laboratories' (ABT) Established Pharmaceuticals Division (EPD) and Diabetes arm are boosting business in recent months.
Stay away from low quality high dividend payers, says Washington Crossing 's Chad Morganlander
02:36pm, Tuesday, 11'th Apr 2023
Gina Sanchez, chief market strategist at Lido Advisors, and Chad Morganlander, senior portfolio manager with Washington Crossing Advisors, joins 'The Exchange' to discuss defensive but expensive divid
My 12 Best Dividend Kings For April 2023
03:38am, Monday, 10'th Apr 2023
The 49 Dividend Kings collectively lost 1 basis point in March but retained a positive year-to-date return. The 12 best dividend kings selected for March, based on forecasted growth and valuation, und
My Dividend Growth Portfolio March Update: Still Accumulating Cash
03:17am, Monday, 10'th Apr 2023
The portfolio remains at record high levels of cash holdings, which is fine for the first time in a long time, cash is providing a decent return. Income growth is projected at 7.9% for the year, up fr
